EE200200620A - IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks - Google Patents

IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks

Info

Publication number
EE200200620A
EE200200620A EEP200200620A EEP200200620A EE200200620A EE 200200620 A EE200200620 A EE 200200620A EE P200200620 A EEP200200620 A EE P200200620A EE P200200620 A EEP200200620 A EE P200200620A EE 200200620 A EE200200620 A EE 200200620A
Authority
EE
Estonia
Prior art keywords
atherosclerosis
medicament
inhibitors
prevention
preparation
Prior art date
Application number
EEP200200620A
Other languages
English (en)
Inventor
Chvatchko Yolande
Tedgui Alain
Mallat Ziad
Original Assignee
Applied Research Systems Ars Holding N.V.
Inserm - Institut National De La Sante Et De La Recherche Medicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V., Inserm - Institut National De La Sante Et De La Recherche Medicale filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200200620A publication Critical patent/EE200200620A/et
Publication of EE05056B1 publication Critical patent/EE05056B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
EEP200200620A 2000-05-05 2001-04-30 IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks EE05056B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00109606 2000-05-05
PCT/EP2001/004843 WO2001085201A2 (en) 2000-05-05 2001-04-30 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis

Publications (2)

Publication Number Publication Date
EE200200620A true EE200200620A (et) 2004-06-15
EE05056B1 EE05056B1 (et) 2008-08-15

Family

ID=8168631

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200620A EE05056B1 (et) 2000-05-05 2001-04-30 IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks

Country Status (33)

Country Link
US (1) US20040076628A1 (et)
EP (1) EP1278540B1 (et)
JP (1) JP5122053B2 (et)
KR (2) KR100798545B1 (et)
CN (2) CN1250286C (et)
AR (1) AR035640A1 (et)
AT (1) ATE395075T1 (et)
AU (2) AU2001267390B2 (et)
BG (1) BG65881B1 (et)
BR (1) BRPI0110506B8 (et)
CA (1) CA2407895C (et)
CY (1) CY1110385T1 (et)
CZ (1) CZ300792B6 (et)
DE (1) DE60134009D1 (et)
DK (1) DK1278540T3 (et)
EA (2) EA007014B1 (et)
EE (1) EE05056B1 (et)
ES (1) ES2305082T3 (et)
HK (2) HK1055681A1 (et)
HR (1) HRP20020828A2 (et)
HU (1) HU229375B1 (et)
IL (2) IL152567A0 (et)
ME (1) ME00554B (et)
MX (1) MXPA02010895A (et)
NO (1) NO329821B1 (et)
PL (1) PL209371B1 (et)
PT (1) PT1278540E (et)
RS (1) RS50926B (et)
SI (1) SI1278540T1 (et)
SK (1) SK287761B6 (et)
UA (2) UA78492C2 (et)
WO (1) WO2001085201A2 (et)
ZA (1) ZA200208228B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102206277A (zh) * 2000-02-10 2011-10-05 雅培制药有限公司 结合人白介素-18的抗体及制备和使用方法
DK1355668T3 (da) * 2001-01-29 2008-05-05 Serono Lab Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom
WO2002096456A1 (en) 2001-05-25 2002-12-05 Ares Trading S.A. Use of il-18 inhibitors for treating or preventing cns injuries
US6797727B2 (en) 2001-07-16 2004-09-28 Transition Therapeutics Inc. Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
SI1487541T1 (sl) 2002-03-22 2009-02-28 Serono Lab Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
ATE399872T1 (de) * 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
WO2004101617A1 (en) 2003-05-13 2004-11-25 Applied Research Systems Ars Holding N.V. Active variants of the il-18 binding protein and medical uses thereof
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US20080044404A1 (en) * 2004-04-15 2008-02-21 Anna Cederholm Annexin V for Preventing Atherothrombosis and Plaque Rupture
CN101219208B (zh) * 2005-01-04 2010-08-11 健能隆医药技术（上海）有限公司 白介素-22的医药用途
DK2267024T3 (da) 2005-06-03 2012-06-25 Ares Trading Sa Fremstilling af rekombinant II-18 bindingsprotein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
EP2609117B1 (en) 2010-08-25 2015-09-16 F.Hoffmann-La Roche Ag Antibodies against il-18r1 and uses thereof
JOP20200308A1 (ar) 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18
MD707Z (ro) * 2013-01-18 2014-07-31 Институт Зоологии Академии Наук Молдовы Metodă de identificare a secvenţelor polimorfe 4a/4b ale genei sintetazei endoteliale a oxidului nitric
HUE055608T2 (hu) 2013-09-05 2021-12-28 Ab2 Bio Sa IL-18-kötõ fehérje (IL-18BP) gyulladásos betegségekben
AU2016227644B2 (en) 2015-03-05 2022-06-16 Ab2 Bio Sa IL-18 Binding Protein (IL-18BP) and antibodies in inflammatory diseases
CN110273591B (zh) 2019-08-13 2023-12-12 上海杉脉电子科技发展有限公司 一种单动力微型智能锁
TW202233675A (zh) 2020-10-29 2022-09-01 瑞士商諾華公司 Ｉｌ－１８拮抗劑用於治療和／或預防異位性皮炎或相關病症之用途
CN112972655A (zh) * 2021-04-16 2021-06-18 武汉大学 白细胞介素12在制备预防、缓解和/或治疗主动脉瘤药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985863A (en) * 1996-09-12 1999-11-16 Vertex Pharmaceuticals, Inc. Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
US5877197A (en) * 1996-12-16 1999-03-02 Karanewsky; Donald S. C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
EP0987552A3 (en) * 1998-08-31 2000-06-07 Pfizer Products Inc. Diarylsulfonylurea binding proteins
WO2000012555A1 (fr) * 1998-09-01 2000-03-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Proteine de liaison de l'interleukine 18

Also Published As

Publication number Publication date
BG107218A (bg) 2003-06-30
CN1841066A (zh) 2006-10-04
EA200201175A1 (ru) 2003-04-24
HUP0301991A3 (en) 2006-11-28
IL152567A0 (en) 2003-05-29
ES2305082T3 (es) 2008-11-01
NO20025307L (no) 2002-12-18
BRPI0110506B8 (pt) 2021-05-25
HK1094909A1 (en) 2007-04-13
YU82602A (sh) 2006-01-16
PL209371B1 (pl) 2011-08-31
JP5122053B2 (ja) 2013-01-16
CA2407895A1 (en) 2001-11-15
SK15562002A3 (sk) 2003-05-02
ATE395075T1 (de) 2008-05-15
UA87658C2 (uk) 2009-08-10
CZ20023644A3 (cs) 2003-03-12
EE05056B1 (et) 2008-08-15
HK1055681A1 (en) 2004-01-21
JP2003532685A (ja) 2003-11-05
KR20030016254A (ko) 2003-02-26
CA2407895C (en) 2012-12-18
BRPI0110506B1 (pt) 2015-05-19
MEP64008A (en) 2011-12-20
EP1278540A2 (en) 2003-01-29
CY1110385T1 (el) 2015-04-29
EA007014B1 (ru) 2006-06-30
HU229375B1 (en) 2013-11-28
ME00554B (me) 2012-03-20
CN1434722A (zh) 2003-08-06
KR20070073989A (ko) 2007-07-10
US20040076628A1 (en) 2004-04-22
NO20025307D0 (no) 2002-11-05
PT1278540E (pt) 2008-07-03
RS50926B (sr) 2010-08-31
CN1841066B (zh) 2012-08-29
SK287761B6 (en) 2011-09-05
AR035640A1 (es) 2004-06-23
EP1278540B1 (en) 2008-05-14
EA005410B1 (ru) 2005-02-24
BR0110506A (pt) 2003-04-01
DK1278540T3 (da) 2008-07-21
DE60134009D1 (de) 2008-06-26
BG65881B1 (bg) 2010-04-30
CZ300792B6 (cs) 2009-08-12
IL152567A (en) 2010-12-30
PL365697A1 (en) 2005-01-10
KR100798545B1 (ko) 2008-01-28
WO2001085201A2 (en) 2001-11-15
NO329821B1 (no) 2010-12-27
UA78492C2 (en) 2007-04-10
HUP0301991A2 (hu) 2003-09-29
EA200401183A1 (ru) 2004-12-30
CN1250286C (zh) 2006-04-12
ZA200208228B (en) 2005-07-27
SI1278540T1 (sl) 2008-10-31
AU6739001A (en) 2001-11-20
HRP20020828A2 (en) 2004-12-31
AU2001267390B2 (en) 2005-09-22
MXPA02010895A (es) 2003-03-27
WO2001085201A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
EE200200620A (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
IL196301A0 (en) Medicament for the treatment of hapatitis c
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
ATE276244T1 (de) Replikationsinhibitoren des respiratorischen synzytialvirus
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
DK1335678T3 (da) Oralt behandlingssystem
HUP0400202A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
MXPA03005731A (es) Articulo absorbente que tiene tratamientos medicinales liberables.
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
EE200200214A (et) Dipüridamooli või mopidamooli kasutamine sellise ravimi valmistamiseks, mis on ette nähtud fibriinsõltuvate mikrotsirkulatsiooni häirete ennetamiseksja raviks
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EE05534B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks kardiomopaatia raviks ja/v?i ennetamiseks
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
EE05174B1 (et) Kemokiini mutandi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette n„htud hulgiskleroosi ja teiste meliinikaotusega seotud haiguste raviks
PL357812A1 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB0105613D0 (en) Pharmaceutically effective compounds and their use
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
HUP0300717A3 (en) Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name